Fun moments at #NACLC23 with IASLC CEO, Dr. Karen Kelly.

What a privilege for my family to meet you! Thank you for your kind words that will last a lifetime in my heart 👏🎖️

In the era of genomic medicine, classical histopathology still has value. LVI is bad player in stage I NSCLC. Staging is imperfect & there’s no data to support adjuvant therapy (except maybe for EGFR mut+)- unmet need! Congrats Maggie (now a resident, to be fellow) #iaslc #NACLC23

#NACLC23 Prioritizing wellness Jay Hepperle Kimberly Novacek Brenda Lewis Christine Litzinger

Thank you very much IASLC for the Education Award!

I’m having such a blast at the #NACLC23 Chicago, IL

It is very nice to connect with friends at #NACLC23 IASLC Congrats dear friend Dr. Xiao Hu! 👏🏼👏🏼👏🏼

Until we meet again… great discussion and plan for future collaborations Narjust Florez, MD, FASCO.

Loved reconnecting with some amazing #womenInScience at #NACLC23 IASLC. Heather Wakelee Karen Kelly Deborah Doroshow Bruna Pellini, MD Sinchita Roy MD PhD Jyoti D Patel and others…

#LCSM Chat #lungcancer

Diversity in Clinical Trials Matter! Poster presented at #NACLC23 IASLC

Patients with brain metastasis are underrepresented in lung cancer CT

ASCO/Friends of Cancer Research/FDA Oncology recommended expanding patient access to CT by broadening eligibility criteria ⬇️

Dr. Sinchita Roy-Chowdhuri (Sinchita Roy MD PhD ) with an excellent talk educating the audience at #NACLC23 on lung cancer biomarker testing.

#pathology #pulmpath #cytopath #lungcancer

Looking forward to present our work on clinical characteristics and outcomes of patients with EGFR mutated NSCLC treated with EGFR targeted therapy then IO.

#NACLC23 #IASLC
#lungcancer #lcsm Mayo Clinic Comprehensive Cancer Center Mayo Clinic Hematology-Oncology Fellowship EGFR Resisters

Dr. Quynh-Nhu Nguyen speaking on #sclc updates #NACLC23 and ongoing NRG studies on immunotherapy +/- consolidative RT and SWOG study on MRI surveillance vs. prophylactic cranial RT.

Looking forward to hearing updates in thoracic oncology #NACLC23

Important discussion by Dr. Pellini surrounding disparities in NGS testing. Highlighting some of the work by Debora Bruno, MD

#NACLC23 Case Comp Cancer Ctr JAGarciaMD

Bright and early!

Day 2 IASLC #NACLC23 💖💖

Dr. Ashley Prosper (Ashley Prosper, MD ) talking about radiology at #NACLC23

#NACLC23 Last leg to ND!! It’s been a great time! Kimberly Novacek Brenda Lewis Jay Hepperle Christine Litzinger

What is this? ⁦Ashley Prosper, MD⁩ teaching some pearls at #NACLC23

Come to the #NACLC23 IASLC poster session later today!

We will discuss more about increasing diversity in lung cancer clinical trials Ana I. Velázquez Mañana, MD MSc (she/her/ella)

THIS! ⬇️ Why we love the #LCSM community.

Was a bit down today not to be able to attend #NACLC23 and be with my stellar mentees and presenters Sarah Waliany, MD, MS and @Justinumab .

But this whole community of amazing thoracic onc colleagues & friends showed up to support/ welcome them ⭐️

📣 Ben Creelan, MD takes the stage at #NACLC23 to give a master class on cellular therapies for lung cancer. If you have not seen Dr. Creelan talk, you are missing out! He makes complex topics easy to understand and is such an engaging speaker 🤩 IASLC Moffitt Cancer Center Moffitt Research

Congratulations to UVA Cancer Center hem/onc fellow, Phil Young, for his poster at #NACLC23 of multi center study of outcomes for recurrences after stage III #NSCLC treated w chemoRT, immunotherapy. Dwight Owen Richard Hall MD, MS